Who owns Neurocrine Biosciences?

Key details on Neurocrine Biosciences (Ticker: NBIX)

Who owns Neurocrine Biosciences?

Is NBIX a good stock to own? Find out who bought Neurocrine Biosciences, who sold Neurocrine Biosciences (NBIX) stock, and who holds a large position in Neurocrine Biosciences.

Fund Name Number of Shares Share Valuation As Of
FMR 11.39M $178.45M Sept. 30, 2014
T. Rowe Price Associates 10.07M $224.95M Dec. 31, 2014
OrbiMed Advisors 5.97M $133.34M Dec. 31, 2014
BVF 5.93M $50.40M Dec. 31, 2011
Perceptive Advisors 5.17M $115.39M Dec. 31, 2014
BB Biotech AG 3.09M $68.95M Dec. 31, 2014
BlackRock Fund Advisors 2.85M $63.65M Dec. 31, 2014
Visium Asset Management 2.46M $55.00M Dec. 31, 2014
Vanguard 2.36M $52.76M Dec. 31, 2014
STATE STREET CORPORATION 2.09M $46.64M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 2.04M $45.54M Dec. 31, 2014
VHCP Management 1.96M $26.29M June 30, 2013
Franklin Resources 1.93M $43.03M Dec. 31, 2014
S.A.C. Capital Advisors 1.88M $14.07M Dec. 31, 2012
Jennison Associates 1.64M $18.59M Sept. 30, 2013

Who sold Neurocrine Biosciences?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wellington Management Company June 30, 2011 1.93M $15.56M